E Buzz Season 1 Episode 287 Ranveer Singh Reacts To The Audience Reviews Of Bajirao Mastani
- December 21, 2015
- 1 min
In E Buzz season 1 episode 287, host Komal Nahta is joined by the multi-talented Ranveer Singh to discuss the audience's response to his latest film, Bajirao Mastani. The episode begins with a clip of fans expressing their admiration for Ranveer's performance as Bajirao, the 18th-century Maratha warrior king.
Ranveer grins as he watches the clips, clearly pleased with the audience's reaction. He then delves into his preparation process for the role, discussing how he read extensive literature on the subject, underwent physical training, and even learned to speak Marathi for the film.
Komal brings up the fact that some viewers criticized the film for historical inaccuracies, prompting Ranveer to defend the director's approach. He explains that while the film is based on real-life events, it is ultimately a work of fiction and does not claim to be a documentary.
The conversation then shifts to the film's music, with Ranveer giving high praise to composer Sanjay Leela Bhansali. He admits that he was initially intimidated by the director's high standards, but ultimately found the experience to be incredibly rewarding.
The episode also features clips of some of the film's other cast members, including Priyanka Chopra and Deepika Padukone. The two leading ladies each express their admiration for Ranveer's work on the film, with Priyanka calling him "a phenomenal actor," and Deepika dubbing him "the soul of the film."
As the episode draws to a close, Ranveer thanks the fans for their support, revealing that he feels "blessed and grateful" for the opportunity to play such a legendary character. He also teases his upcoming projects, including an action-comedy film with Rohit Shetty and a sports drama about the life of Kapil Dev.
Overall, E Buzz season 1 episode 287 provides an insightful look into the making of Bajirao Mastani, with Ranveer Singh offering a charming and informative perspective on the film's critical and commercial success.